Digest Network Come funziona
Network
/
Società
Ic
Non verificato

Ichnos Glenmark Innovation

Di cosa scriviamo

BiologiaBiotecnologiaFarmaceuticaMedicina Salute BenessereSanità

5 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
10/07/2025
Salute
Fitness
Finanza
Risparmio/Affari personali
Fondi di investimento
Imprese
Industria
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
Fonte
Ichnos Glenmark Innovation
Emittente
PR News Wire
1.00
0
02/06/2025
Farmaceutica
Sanità
Biologia
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
Fonte
Ichnos Glenmark Innovation
Emittente
PR News Wire
1.00
0
05/05/2025
Farmaceutica
Sanità
Biologia
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
Fonte
Ichnos Glenmark Innovation
Emittente
PR News Wire
1.00
0
09/12/2024
Biotecnologia
Medicina Salute Benessere
Ichnos Glenmark Innovation (IGI) présente les données cliniques initiales issues de l’étude de phase 1 portant sur l’anticorps trispécifique TREAT™, ISB 2001, démontrant un taux de réponse globale (TRG) élevé avec des réponses durables et un profil d’innocuité favorable chez des patients atteints d’un myélome multiple lourdement prétraités
Fonte
Ichnos Glenmark Innovation
Emittente
GLOBENEWSWIRE
1.00
0
09/12/2024
Biotecnologia
Medicina Salute Benessere
Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma
Fonte
Ichnos Glenmark Innovation
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0